Abatacept: The Evidence for Its Place in the Treatment of Rheumatoid Arthritis

Core Evidence - New Zealand
doi 10.2147/ce.s7427
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Abatacept: A T-Cell Co-Stimulation Modulator for the Treatment of Rheumatoid Arthritis

Clinical Rheumatology
MedicineRheumatology
2008English

The Efficacy and Safety of Abatacept in Rheumatoid Arthritis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2010English

A Critical Evaluation of the Role of Subcutaneous Abatacept in the Treatment of Rheumatoid Arthritis: Patient Considerations

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2014English

Experience With Subcutaneous Abatacept for Rheumatoid Arthritis: An Update for Clinicians

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2014English

Efficacy, Safety, and Tolerability of Abatacept in the Management of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2009English

Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of Up to 8 Years of Treatment From the Abatacept Clinical Trial Program

Journal of Rheumatology
RheumatologyAllergyImmunology
2013English

Effects of Abatacept on Monocytes in Patients With Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

Malignancies in the Rheumatoid Arthritis Abatacept Clinical Development Programme: An Epidemiological Assessment

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2008English

PMS12 a Budget Impact Model for the Use of Abatacept as a First Biologic Treatment for Rheumatoid Arthritis in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy